http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112019001121-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_806167a85d75933d767ba60abd2a63ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f65e858a6204314af582a15abb7af0ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2017-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_595264fb43bbfe74786bc90d045cfdd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6be098b6b9a40e2c2ff55f1e68c0ebc9 |
| publicationDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112019001121-A2 |
| titleOfInvention | compound use, curative or prophylactic seizure pharmaceutical composition |
| abstract | The present invention is in the fields of chemistry, pharmacy, biotechnology and medicine. More specifically, the present invention describes the use of a peptide compound to prepare anticonvulsant medicament, an anticonvulsant pharmaceutical composition, and a therapeutic method. The peptide compound of the pharmaceutical composition of the invention binds and / or modulates the activity of cannabinoid (cb) receptors, especially cb1 and / or cb2, and has been surprisingly useful as an anticonvulsant. In one embodiment, oral administration of the pharmaceutical composition of the invention to a mammal provides excellent anticonvulsant result, which among other advantages and technical effects lacks the disadvantages arising from the use of cannabinoid substances. like cannabidiol - and provides more intense therapeutic effect, with lower dosage and less side effects. |
| priorityDate | 2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.